Neil M Wolfman

USPTO Granted Patents = 39 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 17

Forward Citations = 1,129(Granted Patents)

Location History:

Brookline, MA (US) (1988)
Dover, MA (US) (1992 - 2016)

Company Filing History:

Genetics Institute, Inc.

Cambridge Antibody Technology Limited

patents

7. 1 out of 3,682

The Johns Hopkins University

patents

8. 1 out of 4,119

Wisconsin Alumni Research Foundation

patents

9. 1 out of 1

Genetics, Institute Institute, Llc.

patent

10. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2016

Loading Chart...

39 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9505831 - Isolated cell comprising a nucleic acid encoding antibody inhibitors of gdf-8 and uses thereof (2016-11-29),

2. 8940874 - Neutralizing antibodies against GDF-8 and uses therefor (2015-01-27),

3. 8710202 - Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity (2014-04-29),

4. 8710025 - Modified and stabilized GDF propeptides and uses thereof (2014-04-29),

5. 8420082 - Neutralizing antibodies against GDF-8 and uses therefor (2013-04-16),

6. 8222384 - Modified and stabilized GDF propeptides and uses thereof (2012-07-17),

7. 8092798 - Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 (2012-01-10),

8. 7956038 - GASP1: a follistatin domain containing protein (2011-06-07),

9. 7737116 - Modified and stabilized GDF propeptides and uses thereof (2010-06-15),

10. 7731961 - Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8 (2010-06-08),

11. 7678885 - Recombinant bone morphogenetic protein heterodimers, compositions and methods of use (2010-03-16),

12. 7655763 - Neutralizing antibodies against GDF-8 and uses therefor (2010-02-02),

13. 7585835 - GASP1: a follistatin domain containing protein (2009-09-08),

14. 7572763 - Follistatin domain containing proteins (2009-08-11),

15. 7572599 - Metalloprotease activation of myostatin, and methods of modulating myostatin activity (2009-08-11),

Of course! Here is the article about inventor Neil M Wolfman:

Title: The Inventive Mind of Neil M Wolfman: Pioneering Antibody Inhibitors for Degenerative Disorders

Introduction:

In the realm of biomedical innovations, inventor Neil M Wolfman stands out as a prolific talent based in Dover, MA (US). With an impressive portfolio of 39 patents under his belt, Wolfman has dedicated his career to pushing the boundaries of science and medicine.

Latest Patents:

Neil M Wolfman's latest patents showcase his groundbreaking work in developing antibody inhibitors for growth and differentiation factor-8 (GDF-8). His inventions include "Isolated cell comprising a nucleic acid encoding antibody inhibitors of GDF-8 and uses thereof," which introduces novel antibodies that inhibit GDF-8 activity, offering promising prospects for diagnosing and treating degenerative muscle, bone, and insulin-related disorders. Additionally, Wolfman's "Neutralizing antibodies against GDF-8 and uses therefor" patent highlights his innovative approach in creating antibodies to combat muscle and bone degenerative issues as well as insulin metabolism disorders.

Career Highlights:

Throughout his career, Neil M Wolfman has made noteworthy contributions to the field of biotechnology through his work with esteemed companies such as Wyeth and Genetics Institute, Inc. His tenure at these organizations has been marked by a relentless pursuit of scientific excellence and a commitment to developing cutting-edge solutions for complex health challenges.

Collaborations:

In his professional journey, Neil M Wolfman has collaborated closely with accomplished individuals in the industry, including Geertruida Machteld Veldman and Monique V Davies. Together, they have synergized their expertise to drive forward innovative projects and advance the frontiers of biomedical research.

Conclusion:

In conclusion, Neil M Wolfman's pioneering spirit and inventive prowess have left an indelible mark on the world of biotechnology. His relentless pursuit of innovation and his commitment to improving healthcare outcomes underscore his status as a visionary inventor shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.